Abstract
Radioimmunoconjugates that target lymphoma-associated antigens may be safely combined with high-dose chemotherapy and autologous stem cell transplantation. The most effective and easiest approach for widespread application remains to be determined.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2601-2602 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 106 |
| Issue number | 8 |
| DOIs | |
| State | Published - Oct 2005 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology